ESC Premium Access

De-escalation of antiplatelet therapy after percutaneous coronary intervention in acute coronary syndrome patients: outcome of diabetics in the randomized TROPICAL-ACS trial

Congress Presentation

About the speaker

Doctor Ralph Hein

Municipal Hospital of Munich, Munich (Germany)
0 follower

6 more presentations in this session

Long-term safety and efficacy of the xience everolimus eluting stent in patients at high bleeding risk: a patient-level pooled analysis from four xience post-approval trials

Speaker: Doctor R. Mehran (New York, US)


Diagnostic performance of quantitative flow ratio in diabetic and non-diabetic patients

Speaker: Mr J. Smit (Leiden, NL)


A clinical risk score to predict the presence of obstructive coronary artery disease in asymptomatic patients with type 2 diabetes

Speaker: Assistant Professor C. Kim (Uijungbu, KR)


Impact of glycated hemoglobin in diabetic patients with coronary artery disease undergoing surgery, angioplasty or clinical treatment in a very long-term follow-up

Speaker: Mr E. Martins (Sao Paulo, BR)


Prognostic impact of admission hyperglycemia in acute coronary syndrome patients and its interaction with diabetes mellitus history and metabolic control.

Speaker: Doctor J. Alves Guimaraes (Lisbon, PT)


Access the full session

Diabetes-associated coronary artery disease

Speakers: Doctor R. Hein, Doctor R. Mehran, Mr J. Smit, Assistant Professor C. Kim, Mr E. Martins...

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb